215 related articles for article (PubMed ID: 11352248)
1. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
2. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
3. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
4. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
[TBL] [Abstract][Full Text] [Related]
5. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE
Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
Lovell DJ; Giannini EH; Reiff A; Jones OY; Schneider R; Olson JC; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Lange M; Finck BK; Burge DJ;
Arthritis Rheum; 2003 Jan; 48(1):218-26. PubMed ID: 12528122
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
9. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
[TBL] [Abstract][Full Text] [Related]
10. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Reinhold-Keller E; Fink CO; Herlyn K; Gross WL; De Groot K
Arthritis Rheum; 2002 Jun; 47(3):326-32. PubMed ID: 12115164
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
Moreland LW; Cohen SB; Baumgartner SW; Tindall EA; Bulpitt K; Martin R; Weinblatt M; Taborn J; Weaver A; Burge DJ; Schiff MH
J Rheumatol; 2001 Jun; 28(6):1238-44. PubMed ID: 11409115
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Martin Mola E; Pedersen R; Robertson D; Chang D; Koenig A; Freundlich B;
Ann Rheum Dis; 2009 Jul; 68(7):1113-8. PubMed ID: 18718986
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
14. Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
Fleischmann RM; Baumgartner SW; Tindall EA; Weaver AL; Moreland LW; Schiff MH; Martin RW; Spencer-Green GT
J Rheumatol; 2003 Apr; 30(4):691-6. PubMed ID: 12672185
[TBL] [Abstract][Full Text] [Related]
15. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
Stone JH; Tun W; Hellman DB
J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
17. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
[TBL] [Abstract][Full Text] [Related]
18. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
[TBL] [Abstract][Full Text] [Related]
19. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
Stone JH; Hoffman GS; Merkel PA; Min YI; Uhlfelder ML; Hellmann DB; Specks U; Allen NB; Davis JC; Spiera RF; Calabrese LH; Wigley FM; Maiden N; Valente RM; Niles JL; Fye KH; McCune JW; St Clair EW; Luqmani RA;
Arthritis Rheum; 2001 Apr; 44(4):912-20. PubMed ID: 11318006
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of remission with leflunomide in Wegener's granulomatosis.
Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]